Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.27% | 20.24% | 28.39% | 25.54% | 22.46% |
| Total Depreciation and Amortization | -14.26% | -26.85% | -58.31% | -70.85% | -74.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.04% | -88.36% | -97.84% | 2,181.17% | 72.18% |
| Change in Net Operating Assets | 191.83% | 155.30% | -150.90% | -97.79% | -194.96% |
| Cash from Operations | 22.59% | 33.86% | 15.68% | 12.69% | 5.93% |
| Capital Expenditure | 43.36% | 99.72% | 99.72% | 31.99% | 56.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 43.36% | 99.72% | 99.72% | 31.99% | 56.45% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | 99.80% | 99.80% | 91.85% | -44,431.11% | -41,645.83% |
| Issuance of Common Stock | -30.85% | -68.13% | -71.84% | 68.34% | 658.71% |
| Repurchase of Common Stock | -- | -- | -- | 73.33% | 99.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.09% | 74.83% | 79.44% | -0.63% | -344.11% |
| Cash from Financing | -30.63% | -66.95% | -72.01% | 87.75% | 819.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.78% | -493.84% | -222.22% | 111.04% | 126.48% |